首页 > 最新文献

Saudi Medical Journal最新文献

英文 中文
Drug-coated balloons versus conventional percutaneous transluminal angioplasty for treatment-naïve dysfunctional arteriovenous fistulas.: A 10-year single center retrospective study. 药物涂层球囊与传统经皮腔内血管成形术治疗无效的功能障碍动静脉瘘:一项为期10年的单中心回顾性研究。
IF 1.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-01 DOI: 10.15537/smj.2024.45.7.20230852
Abdulaziz AlQubaisi, Mohammad Arabi, Yousof AlZahrani, Omar Bashir

Objectives: To compare the primary patency and restenosis rates in treatment naieve dialysis arteriovenous fistulas (AVFs) after drug-coated balloons (DCB) versus plain balloon angioplasty (PTA).

Methods: This retrospective study included 157 patients who underwent AVF angioplasty for treatment-native AVF stenosis between January 2012 to 2022. The fistulas were Brachiocephalic (75%), Brachiobasilic (17%), and radiocephalic (8%). The index intervention was with either DCB or percutaneous transluminal angioplasty (PTA) with subsequent follow up. Patients with central venous stenosis, thrombosed fistula, fistula stents, AV graft or surgical intervention after the index procedure were excluded.

Results: Arteriovenous fistula angioplasty was done in 28 patients using DCB and in 129 patients using PTA. A total of 108 patients presented with a single stenosis, 42 with 2 stenoses, and 7 with 3 stenoses. The location of these stenoses was in the venous outflow (57%), the juxta anastomotic segment (31%), and cephalic arch (12%). The median time to re-intervention for the PTA was 216 days compared to 304 days for the DCB (p=0.079). Primary patency at 6 months was 60.4% for PTA and 75% for DCB (p=0.141) CONCLUSION: Although DCB angioplasty of treatmentnaïve dysfunctional AVF tends to improve the time to intervention and 6-month primary patency compared to PTA, this difference did not reach statistical significance.

目的比较药物涂层球囊(DCB)与普通球囊血管成形术(PTA)治疗无效透析动静脉瘘(AVF)的初次通畅率和再狭窄率:这项回顾性研究纳入了 2012 年 1 月至 2022 年期间因治疗原发性动静脉瘘狭窄而接受动静脉瘘血管成形术的 157 例患者。瘘管为肱动脉(75%)、肱动脉(17%)和放射脑动脉(8%)。指标干预采用 DCB 或经皮腔内血管成形术 (PTA),并进行后续随访。排除了中心静脉狭窄、瘘管血栓形成、瘘管支架、动静脉移植或在指数手术后进行外科干预的患者:结果:28 名患者使用 DCB 进行了动静脉瘘血管成形术,129 名患者使用 PTA 进行了动静脉瘘血管成形术。共有 108 名患者出现单处狭窄,42 名患者出现 2 处狭窄,7 名患者出现 3 处狭窄。这些狭窄的位置分别位于静脉流出段(57%)、吻合段(31%)和头弓段(12%)。PTA 再介入的中位时间为 216 天,而 DCB 为 304 天(P=0.079)。结论:虽然与 PTA 相比,DCB 血管成形术治疗无效的功能障碍 AVF 往往能缩短介入时间并提高 6 个月的主要通畅率,但这一差异未达到统计学意义。
{"title":"Drug-coated balloons versus conventional percutaneous transluminal angioplasty for treatment-naïve dysfunctional arteriovenous fistulas.: A 10-year single center retrospective study.","authors":"Abdulaziz AlQubaisi, Mohammad Arabi, Yousof AlZahrani, Omar Bashir","doi":"10.15537/smj.2024.45.7.20230852","DOIUrl":"10.15537/smj.2024.45.7.20230852","url":null,"abstract":"<p><strong>Objectives: </strong>To compare the primary patency and restenosis rates in treatment naieve dialysis arteriovenous fistulas (AVFs) after drug-coated balloons (DCB) versus plain balloon angioplasty (PTA).</p><p><strong>Methods: </strong>This retrospective study included 157 patients who underwent AVF angioplasty for treatment-native AVF stenosis between January 2012 to 2022. The fistulas were Brachiocephalic (75%), Brachiobasilic (17%), and radiocephalic (8%). The index intervention was with either DCB or percutaneous transluminal angioplasty (PTA) with subsequent follow up. Patients with central venous stenosis, thrombosed fistula, fistula stents, AV graft or surgical intervention after the index procedure were excluded.</p><p><strong>Results: </strong>Arteriovenous fistula angioplasty was done in 28 patients using DCB and in 129 patients using PTA. A total of 108 patients presented with a single stenosis, 42 with 2 stenoses, and 7 with 3 stenoses. The location of these stenoses was in the venous outflow (57%), the juxta anastomotic segment (31%), and cephalic arch (12%). The median time to re-intervention for the PTA was 216 days compared to 304 days for the DCB (<i>p</i>=0.079). Primary patency at 6 months was 60.4% for PTA and 75% for DCB (<i>p</i>=0.141) CONCLUSION: Although DCB angioplasty of treatmentnaïve dysfunctional AVF tends to improve the time to intervention and 6-month primary patency compared to PTA, this difference did not reach statistical significance.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11237285/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141493186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WHO unveils a digital health promoter harnessing generative AI for public health. 世卫组织推出利用生成式人工智能促进公共卫生的数字健康促进器。
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2024-06-01
{"title":"WHO unveils a digital health promoter harnessing generative AI for public health.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147597/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141238426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the correlation between the degree of tricuspid regurgitation and pulmonary hypertension: A comprehensive study. 评估三尖瓣反流程度与肺动脉高压之间的相关性:一项综合研究
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2024-06-01 DOI: 10.15537/smj.2024.45.6.20240071
Jamilah S AlRahimi, Yasser M Ismail, Noor A Aljubairi, Nawal W Kutob, Ghadi S Bakulka, Ruqayyah A Ahmed, Fatima A Ahmed, Ali A Haneef

Objectives: To evaluate the relationship between severity of tricuspid regurgitation (TR) and pulmonary hypertension.

Methods: Cross-sectional study of 118 patients with pulmonary hypertension was carried out at a single center in Jeddah, Saudi Arabia, between 2018-2021. Patients who had pulmonary or tricuspid valves organic diseases, previously undergone tricuspid or pulmonary valve surgeries, had permanent pacemakers or critically ill were excluded.

Results: A high proportion of patients were women (n=100, 85%) and obese (n=57, 48%). Patients with more than mild TR had higher systolic pulmonary artery pressure (sPAP) than those with trivial or mild regurgitation (p<0.001). There was a significant association between severity of TR (p<0.001) and right chambers size (p=0.001). Furthermore, pulmonary artery pressure (PAP) was significantly higher in patients with mild right ventricular impairment (p=0.001).

Conclusion: Increase in degree of TR and right atrial size were predictors of elevated sPAP. Our findings highlight the interplay among TR, right heart size, ventricular function, and PAP. Understanding these associations can aid in risk stratification, monitoring disease progression, and potentially guiding treatment in those patients.

目的:评估三尖瓣反流(TR)的严重程度与肺动脉高压之间的关系:评估三尖瓣反流(TR)严重程度与肺动脉高压之间的关系:2018-2021年间,沙特阿拉伯吉达市的一家中心对118名肺动脉高压患者进行了横断面研究。排除了患有肺动脉瓣或三尖瓣器质性疾病、曾接受过三尖瓣或肺动脉瓣手术、拥有永久性心脏起搏器或重症患者:大部分患者为女性(100人,占85%)和肥胖者(57人,占48%)。轻度以上TR患者的肺动脉收缩压(sPAP)高于轻微或轻度反流患者(ppp=0.001)。此外,右心室轻度受损患者的肺动脉压(PAP)明显更高(P=0.001):结论:TR程度和右心房大小的增加是sPAP升高的预测因素。我们的研究结果突显了 TR、右心大小、心室功能和血压之间的相互作用。了解这些关联有助于对患者进行风险分层、监测疾病进展并指导治疗。
{"title":"Assessing the correlation between the degree of tricuspid regurgitation and pulmonary hypertension: A comprehensive study.","authors":"Jamilah S AlRahimi, Yasser M Ismail, Noor A Aljubairi, Nawal W Kutob, Ghadi S Bakulka, Ruqayyah A Ahmed, Fatima A Ahmed, Ali A Haneef","doi":"10.15537/smj.2024.45.6.20240071","DOIUrl":"10.15537/smj.2024.45.6.20240071","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the relationship between severity of tricuspid regurgitation (TR) and pulmonary hypertension.</p><p><strong>Methods: </strong>Cross-sectional study of 118 patients with pulmonary hypertension was carried out at a single center in Jeddah, Saudi Arabia, between 2018-2021. Patients who had pulmonary or tricuspid valves organic diseases, previously undergone tricuspid or pulmonary valve surgeries, had permanent pacemakers or critically ill were excluded.</p><p><strong>Results: </strong>A high proportion of patients were women (n=100, 85%) and obese (n=57, 48%). Patients with more than mild TR had higher systolic pulmonary artery pressure (sPAP) than those with trivial or mild regurgitation (<i>p</i><0.001). There was a significant association between severity of TR (<i>p</i><0.001) and right chambers size (<i>p</i>=0.001). Furthermore, pulmonary artery pressure (PAP) was significantly higher in patients with mild right ventricular impairment (<i>p</i>=0.001).</p><p><strong>Conclusion: </strong>Increase in degree of TR and right atrial size were predictors of elevated sPAP. Our findings highlight the interplay among TR, right heart size, ventricular function, and PAP. Understanding these associations can aid in risk stratification, monitoring disease progression, and potentially guiding treatment in those patients.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147589/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141238264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do digital health information searches of individuals with chronic diseases affect health literacy and patient empowerment? A path analysis. 慢性病患者的数字健康信息搜索会影响健康素养和患者能力吗?路径分析
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2024-06-01 DOI: 10.15537/smj.2024.45.6.20240158
Şenay Şener, Seda Göger

Objectives: To analyze the relationship between chronically ill patients' behaviors in acquiring and verifying health information from a digital environment with health literacy and patient empowerment using a structural equation modeling approach.

Methods: This study was carried out in a public hospital in Turkey between February and May 2023. The study consisted of 365 participants and used descriptive and correlation-based designs for statistical analyses. It also executed computations for descriptive statistics and correlations to carry out a path analysis to assess model fitness and to identify direct and indirect effects.

Results: This study identified that Web 1.0 and health information acquisition and digital verification variables statistically and significantly affected access to information, understanding information, appraisal (valuing)/evaluation, and application/use variables. The study also found that access to information variables was statistically significant on identity/identicalness, self-control, decision-making, and recognition and comprehension. The tested model fit the data well and adequately explained the direct effects of the variables.

Conclusion: The study concluded by suggestively improving the chronically ill patients' media or digital literacy levels through special training to stimulate their internet use effectively.

目的采用结构方程建模法分析慢性病患者从数字环境中获取和验证健康信息的行为与健康素养和患者能力之间的关系:本研究于 2023 年 2 月至 5 月在土耳其一家公立医院进行。研究包括 365 名参与者,采用描述性和相关性设计进行统计分析。研究还对描述性统计和相关性进行了计算,以开展路径分析,评估模型的适宜性并确定直接和间接效应:本研究发现,Web 1.0 和健康信息获取及数字验证变量在统计上对信息获取、信息理解、评价(估值)/评估和应用/使用变量产生了显著影响。研究还发现,获取信息变量对身份/同一性、自我控制、决策以及识别和理解具有统计学意义。所测试的模型很好地拟合了数据,并充分解释了变量的直接影响:本研究的结论是,建议通过特殊培训提高慢性病患者的媒体或数字素养水平,以有效刺激他们使用互联网。
{"title":"Do digital health information searches of individuals with chronic diseases affect health literacy and patient empowerment? A path analysis.","authors":"Şenay Şener, Seda Göger","doi":"10.15537/smj.2024.45.6.20240158","DOIUrl":"10.15537/smj.2024.45.6.20240158","url":null,"abstract":"<p><strong>Objectives: </strong>To analyze the relationship between chronically ill patients' behaviors in acquiring and verifying health information from a digital environment with health literacy and patient empowerment using a structural equation modeling approach.</p><p><strong>Methods: </strong>This study was carried out in a public hospital in Turkey between February and May 2023. The study consisted of 365 participants and used descriptive and correlation-based designs for statistical analyses. It also executed computations for descriptive statistics and correlations to carry out a path analysis to assess model fitness and to identify direct and indirect effects.</p><p><strong>Results: </strong>This study identified that Web 1.0 and health information acquisition and digital verification variables statistically and significantly affected access to information, understanding information, appraisal (valuing)/evaluation, and application/use variables. The study also found that access to information variables was statistically significant on identity/identicalness, self-control, decision-making, and recognition and comprehension. The tested model fit the data well and adequately explained the direct effects of the variables.</p><p><strong>Conclusion: </strong>The study concluded by suggestively improving the chronically ill patients' media or digital literacy levels through special training to stimulate their internet use effectively.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147591/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141238319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on: Effect of cortisol and glycosylated-hemoglobin levels on mortality in intensive care unit. 评论:皮质醇和糖化血红蛋白水平对重症监护病房死亡率的影响。
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2024-06-01 DOI: 10.15537/smj.2024.45.6.20240443
Ghadah B Alanazi, Maysah G Amer
{"title":"Comments on: Effect of cortisol and glycosylated-hemoglobin levels on mortality in intensive care unit.","authors":"Ghadah B Alanazi, Maysah G Amer","doi":"10.15537/smj.2024.45.6.20240443","DOIUrl":"10.15537/smj.2024.45.6.20240443","url":null,"abstract":"","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147603/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141238270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of candidemia risk factors and Candida species distribution in intensive care units among patients with and without COVID-19. 评估重症监护病房中患有和未患有 COVID-19 的患者的念珠菌血症风险因素和念珠菌物种分布。
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2024-06-01 DOI: 10.15537/smj.2024.45.6.20240102
Cemile Uyar, Emel Yıldız, Özlem Genç, Öznur Ak, Emel Koçak, Sevil Alkan, Canan Balcı, Pınar Korkmaz, Duru Mıstanoğlu Özatağ, Halil Aslan

Objectives: To assess the risk variables related to the types of candidemia for each patient, who was admitted into the intensive care unit regardless of the patient with or without complete diagnosis of COVID-19, during the period of March 2019 to December 2022.

Methods: The evaluation comparison of demographic and clinical data of COVID-19 positive and negative patients with candidemia confirmed in blood, 113 cases were assessed. Variables such as gender, age, age of hospitalization, history of hospitalization, concurrently infection, The acute physiology and chronic health evaluation-II scores, comorbidity checking, intubation, central venous catheter use, parenteral nutrition use, steroid use, antibiotic use, lymphopenia, and laboratory variables were evaluated. Candida species distribution, antifungal susceptibility in blood culture were determined.

Results: Coronavirus disease-19 was present in 62.8% of cases confirmed candidemia, and these cases were significantly different from COVID-19 negative cases. Significance was found in more intubation, central venous catheter use, parenteral nutrition, and steroid therapy in Group 2. There was no significance with species distribution and associated infection. In total, COVID-19 positive had higher hemoglobin, aspartate aminotransferase, alanine transaminase, and white blood cell levels, which may be associated with the possibility of revealing and controlling candidemia.

Conclusion: Candida albicans and Candida Parapsilosis (C. parapsilosis) are the species seen in infected COVID-19 patients, while C. parapsilosis and Candida tropicalis are found in non-COVID-19 ones. Risk factors were intubation, parenteral nutrition, central venous catheter, and steroid in the COVID-19 group.

目的评估2019年3月至2022年12月期间,重症监护室收治的每位患者与念珠菌血症类型相关的风险变量,无论患者是否完全确诊COVID-19:对113例血液中确诊为念珠菌血症的COVID-19阳性和阴性患者的人口统计学和临床数据进行评估比较。评估变量包括性别、年龄、住院年龄、住院史、并发感染、急性生理学和慢性健康评估-II评分、合并症检查、插管、中心静脉导管使用、肠外营养使用、类固醇使用、抗生素使用、淋巴细胞减少以及实验室变量。对血液培养中念珠菌的种类分布和抗真菌药敏性进行了测定:结果:62.8%的确诊念珠菌血症病例存在冠状病毒病-19,这些病例与冠状病毒病-19阴性病例有显著差异。在第 2 组中,插管、使用中心静脉导管、肠外营养和类固醇治疗的病例较多,这一点很重要。总之,COVID-19 阳性者的血红蛋白、天门冬氨酸氨基转移酶、丙氨酸转氨酶和白细胞水平较高,这可能与揭示和控制念珠菌血症的可能性有关:结论:白念珠菌和副丝状念珠菌(C. parapsilosis)是感染 COVID-19 的患者中出现的菌种,而副丝状念珠菌和热带念珠菌则出现在非 COVID-19 患者中。COVID-19 组的风险因素包括插管、肠外营养、中心静脉导管和类固醇。
{"title":"Evaluation of candidemia risk factors and <i>Candida</i> species distribution in intensive care units among patients with and without COVID-19.","authors":"Cemile Uyar, Emel Yıldız, Özlem Genç, Öznur Ak, Emel Koçak, Sevil Alkan, Canan Balcı, Pınar Korkmaz, Duru Mıstanoğlu Özatağ, Halil Aslan","doi":"10.15537/smj.2024.45.6.20240102","DOIUrl":"10.15537/smj.2024.45.6.20240102","url":null,"abstract":"<p><strong>Objectives: </strong>To assess the risk variables related to the types of candidemia for each patient, who was admitted into the intensive care unit regardless of the patient with or without complete diagnosis of COVID-19, during the period of March 2019 to December 2022.</p><p><strong>Methods: </strong>The evaluation comparison of demographic and clinical data of COVID-19 positive and negative patients with candidemia confirmed in blood, 113 cases were assessed. Variables such as gender, age, age of hospitalization, history of hospitalization, concurrently infection, The acute physiology and chronic health evaluation-II scores, comorbidity checking, intubation, central venous catheter use, parenteral nutrition use, steroid use, antibiotic use, lymphopenia, and laboratory variables were evaluated. <i>Candida</i> species distribution, antifungal susceptibility in blood culture were determined.</p><p><strong>Results: </strong>Coronavirus disease-19 was present in 62.8% of cases confirmed candidemia, and these cases were significantly different from COVID-19 negative cases. Significance was found in more intubation, central venous catheter use, parenteral nutrition, and steroid therapy in Group 2. There was no significance with species distribution and associated infection. In total, COVID-19 positive had higher hemoglobin, aspartate aminotransferase, alanine transaminase, and white blood cell levels, which may be associated with the possibility of revealing and controlling candidemia.</p><p><strong>Conclusion: </strong><i>Candida albicans</i> and <i>Candida Parapsilosis</i> (<i>C. parapsilosis</i>) are the species seen in infected COVID-19 patients, while C. parapsilosis and <i>Candida tropicalis</i> are found in non-COVID-19 ones. Risk factors were intubation, parenteral nutrition, central venous catheter, and steroid in the COVID-19 group.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147592/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141238352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of sarcopenia and vitamin D levels on the severity of lower urinary tract symptoms in older males. 肌肉疏松症和维生素 D 水平对老年男性下尿路症状严重程度的影响。
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2024-06-01 DOI: 10.15537/smj.2024.45.6.20240166
Deniz M Surmeli, Hulusi C Karpuzcu, Volkan Atmis, Caglar Cosarderelioglu, Ahmet Yalcin, Murat Varli, Sevgi Aras

Objectives: To assess the impact of sarcopenia and vitamin D levels on the severity of lower urinary tract symptoms (LUTS).

Methods: A total of 193 male patients, aged 60 years and above, who visited the geriatric outpatient clinic at Ibn-i Sina Hospital in Ankara, Turkey, between December 2019 and March 2021, were enrolled. Sarcopenia was diagnosed according to the criteria set by the European Working Group on Sarcopenia in Older People. The presence and severity of lower urinary tract symptoms were assessed using the International Prostate Symptom Score questionnaire, categorizing symptom severity as mild or moderate-to-severe.

Results: The median patient age was 71 years (range: 66-77). Sarcopenia affected 24.9% of the population studied. Mild LUTS was observed in 43.5% and moderate-to-severe LUTS was observed in 56.5% of patients. Sarcopenia prevalence was significantly higher in the individuals with moderate-to-severe LUTS compared to those with mild-LUTS (p=0.021). After adjusting for Charlson comorbidity index and age, only vitamin D levels were significantly associated with increased odds of moderate-to-severe LUTS (odds ratio [OR]=0.95, 95% confidence interval [CI]: [0.92-0.98], p=0.002). Sarcopenia was not significantly associated with the severity of LUTS (OR=2.04, 95% CI: [0.94-4.45], p=0.070). An inverse linear trend was observed between quartiles of 25 (OH) vitamin D and LUTS severity. As 25 (OH)vitamin D levels increased, the proportion of patients with moderate-to-severe LUTS decreased (p=0.023).

Conclusion: Sarcopenia did not significantly impact LUTS severity, but low vitamin D levels were associated with moderate-to-severe LUTS.

目的:评估肌肉疏松症和维生素 D 水平对下尿路症状(LUTS)严重程度的影响:评估肌肉疏松症和维生素 D 水平对下尿路症状(LUTS)严重程度的影响:在2019年12月至2021年3月期间,土耳其安卡拉Ibn-i Sina医院老年门诊共收治了193名60岁及以上的男性患者。根据欧洲老年人肌肉疏松症工作组制定的标准诊断肌肉疏松症。下尿路症状的存在和严重程度使用国际前列腺症状评分问卷进行评估,症状严重程度分为轻度和中重度:患者年龄中位数为 71 岁(范围:66-77 岁)。24.9%的研究对象患有肌肉疏松症。43.5%的患者出现轻度尿失禁,56.5%的患者出现中重度尿失禁。与轻度 LUTS 患者相比,中重度 LUTS 患者的肌少症患病率明显更高(p=0.021)。在对夏尔森合并症指数和年龄进行调整后,只有维生素 D 水平与中重度 LUTS 的几率增加显著相关(几率比 [OR]=0.95, 95% 置信区间 [CI]: [0.92-0.98], p=0.002)。肌肉疏松症与 LUTS 的严重程度无明显关系(OR=2.04,95% 置信区间:[0.94-4.45],P=0.070)。25 (OH) 维生素 D 的四分位数与 LUTS 严重程度之间呈反向线性趋势。随着 25 (OH) 维生素 D 水平的升高,中度至重度 LUTS 患者的比例下降(p=0.023):结论:肌肉疏松症对 LUTS 严重程度的影响不大,但维生素 D 水平低与中度至重度 LUTS 有关。
{"title":"Impact of sarcopenia and vitamin D levels on the severity of lower urinary tract symptoms in older males.","authors":"Deniz M Surmeli, Hulusi C Karpuzcu, Volkan Atmis, Caglar Cosarderelioglu, Ahmet Yalcin, Murat Varli, Sevgi Aras","doi":"10.15537/smj.2024.45.6.20240166","DOIUrl":"10.15537/smj.2024.45.6.20240166","url":null,"abstract":"<p><strong>Objectives: </strong>To assess the impact of sarcopenia and vitamin D levels on the severity of lower urinary tract symptoms (LUTS).</p><p><strong>Methods: </strong>A total of 193 male patients, aged 60 years and above, who visited the geriatric outpatient clinic at Ibn-i Sina Hospital in Ankara, Turkey, between December 2019 and March 2021, were enrolled. Sarcopenia was diagnosed according to the criteria set by the European Working Group on Sarcopenia in Older People. The presence and severity of lower urinary tract symptoms were assessed using the International Prostate Symptom Score questionnaire, categorizing symptom severity as mild or moderate-to-severe.</p><p><strong>Results: </strong>The median patient age was 71 years (range: 66-77). Sarcopenia affected 24.9% of the population studied. Mild LUTS was observed in 43.5% and moderate-to-severe LUTS was observed in 56.5% of patients. Sarcopenia prevalence was significantly higher in the individuals with moderate-to-severe LUTS compared to those with mild-LUTS (<i>p</i>=0.021). After adjusting for Charlson comorbidity index and age, only vitamin D levels were significantly associated with increased odds of moderate-to-severe LUTS (odds ratio [OR]=0.95, 95% confidence interval [CI]: [0.92-0.98], <i>p</i>=0.002). Sarcopenia was not significantly associated with the severity of LUTS (OR=2.04, 95% CI: [0.94-4.45], <i>p</i>=0.070). An inverse linear trend was observed between quartiles of 25 (OH) vitamin D and LUTS severity. As 25 (OH)vitamin D levels increased, the proportion of patients with moderate-to-severe LUTS decreased (<i>p</i>=0.023).</p><p><strong>Conclusion: </strong>Sarcopenia did not significantly impact LUTS severity, but low vitamin D levels were associated with moderate-to-severe LUTS.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147587/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141238380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of thyroid disorders among the diabetic population in Arar, Saudi Arabia. 沙特阿拉伯阿拉尔地区糖尿病患者中甲状腺疾病的患病率。
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2024-06-01 DOI: 10.15537/smj.2024.45.6.20240144
Haider O Elmisbah, Riyad Y Laham, Hafiz O Almisbah, Hadeel T Alanazi, Taif A Alanazi, Raghad M Alanzi, Wejdan A Aldahmashi, Anshoo Agarwal, Rashad Q Othman

Objectives: To study the prevalence of thyroid disorders (TDs) among the diabetic population in Arar, Saudi Arabia.

Methods: A cross-sectional design study carried out in Arar, northern province of Saudi Arabia, from October 2023 to January 2024. A structured questionnaire was used to collect the data. From the diabetic population aged over 18 years old.

Results: A total of 501 participants were enrolled. Most fall within the 20-35 age range, comprising 36.5% of the sample. Vitamin D deficiency appears to be the most prevalent comorbid condition. Following closely behind is vitamin B12 deficiency; hypertension and high blood lipids also show notable prevalence rates, affecting 10.5-22.1% of the population. In terms of diabetes, 42.8% of the population has been diagnosed with the condition. Among those with diabetes, the majority (67.6%) have been diagnosed with the second type, while 32.4% have the first type. There is an association between diabetes and TDs, with 51.3% of participants reporting this.

Conclusion: The findings indicate that the adults in Arar, Saudi Arabia, lack some knowledge of TDs and their relationship to diabetes.

目的:研究沙特阿拉伯阿拉尔市糖尿病人群中甲状腺疾病(TDs)的发病率:研究沙特阿拉伯阿拉尔糖尿病人群中甲状腺疾病(TDs)的患病率:方法:2023 年 10 月至 2024 年 1 月在沙特阿拉伯北部省阿拉尔市开展了一项横断面设计研究。采用结构化问卷收集数据。研究对象为 18 岁以上的糖尿病患者:共有 501 人参加了调查。大多数人的年龄在 20-35 岁之间,占样本的 36.5%。维生素 D 缺乏似乎是最普遍的合并症。紧随其后的是维生素 B12 缺乏症;高血压和高血脂的发病率也很高,占总人口的 10.5%-22.1%。在糖尿病方面,42.8%的人口被诊断出患有糖尿病。在糖尿病患者中,大多数(67.6%)被诊断为第二型糖尿病,32.4%为第一型糖尿病。51.3% 的参与者表示糖尿病与泪腺炎有关联:研究结果表明,沙特阿拉伯阿拉尔的成年人对糖尿病及其与糖尿病的关系缺乏一定的了解。
{"title":"Prevalence of thyroid disorders among the diabetic population in Arar, Saudi Arabia.","authors":"Haider O Elmisbah, Riyad Y Laham, Hafiz O Almisbah, Hadeel T Alanazi, Taif A Alanazi, Raghad M Alanzi, Wejdan A Aldahmashi, Anshoo Agarwal, Rashad Q Othman","doi":"10.15537/smj.2024.45.6.20240144","DOIUrl":"10.15537/smj.2024.45.6.20240144","url":null,"abstract":"<p><strong>Objectives: </strong>To study the prevalence of thyroid disorders (TDs) among the diabetic population in Arar, Saudi Arabia.</p><p><strong>Methods: </strong>A cross-sectional design study carried out in Arar, northern province of Saudi Arabia, from October 2023 to January 2024. A structured questionnaire was used to collect the data. From the diabetic population aged over 18 years old.</p><p><strong>Results: </strong>A total of 501 participants were enrolled. Most fall within the 20-35 age range, comprising 36.5% of the sample. Vitamin D deficiency appears to be the most prevalent comorbid condition. Following closely behind is vitamin B12 deficiency; hypertension and high blood lipids also show notable prevalence rates, affecting 10.5-22.1% of the population. In terms of diabetes, 42.8% of the population has been diagnosed with the condition. Among those with diabetes, the majority (67.6%) have been diagnosed with the second type, while 32.4% have the first type. There is an association between diabetes and TDs, with 51.3% of participants reporting this.</p><p><strong>Conclusion: </strong>The findings indicate that the adults in Arar, Saudi Arabia, lack some knowledge of TDs and their relationship to diabetes.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141238422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of denosumab treatment for lung metastasis secondary to proximal humerus chondroblastoma. 地诺单抗治疗肱骨近端软骨母细胞瘤继发肺转移的疗效。
IF 1.7 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-06-01 DOI: 10.15537/smj.2024.45.6.20230720
Ramy Samargandi, Mathilde Bernard, Elodie Miquelestorena-Standley, Louis Romée Le Nail

Chondroblastoma is a rare benign cartilaginous tumor that accounts for approximately 1% of bone tumors, but it can be associated with lung metastasis in extremely rare cases, leading to a poor prognosis and death. Herein, we report the case of a 19-year-old male patient who presented with an aggressive chondroblastoma of the proximal humerus and bilateral lung metastasis. The patient was treated with wide local resection, partial metastasectomy, and denosumab. Denosumab treatment was effective in controlling metastatic progression and preventing local recurrence.

软骨母细胞瘤是一种罕见的良性软骨肿瘤,约占骨肿瘤的1%,但在极少数情况下可伴有肺转移,导致预后不良和死亡。在此,我们报告了一例 19 岁男性患者的病例,该患者患有侵袭性肱骨近端软骨母细胞瘤,并伴有双侧肺转移。患者接受了局部广泛切除术、部分转移灶切除术和地诺单抗治疗。地诺单抗治疗在控制转移进展和预防局部复发方面效果显著。
{"title":"Efficacy of denosumab treatment for lung metastasis secondary to proximal humerus chondroblastoma.","authors":"Ramy Samargandi, Mathilde Bernard, Elodie Miquelestorena-Standley, Louis Romée Le Nail","doi":"10.15537/smj.2024.45.6.20230720","DOIUrl":"10.15537/smj.2024.45.6.20230720","url":null,"abstract":"<p><p>Chondroblastoma is a rare benign cartilaginous tumor that accounts for approximately 1% of bone tumors, but it can be associated with lung metastasis in extremely rare cases, leading to a poor prognosis and death. Herein, we report the case of a 19-year-old male patient who presented with an aggressive chondroblastoma of the proximal humerus and bilateral lung metastasis. The patient was treated with wide local resection, partial metastasectomy, and denosumab. Denosumab treatment was effective in controlling metastatic progression and preventing local recurrence.</p>","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147590/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141238348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How does aspirin help prevent colorectal cancer development and progression? 阿司匹林如何帮助预防结直肠癌的发生和发展?
IF 1.6 4区 医学 Q2 Medicine Pub Date : 2024-06-01
{"title":"How does aspirin help prevent colorectal cancer development and progression?","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147593/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141238372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Saudi Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1